Activation of coagulation and fibrinolysis in acute respiratory distress syndrome: A prospective pilot study

Frontiers in Medicine

Volumn 3, Issue NOV, 2016, Pages

  Ozolina, Agnese ^a,b   Sarkele, Marina ^a,b   Sabelnikovs, Olegs ^a,b   Skesters, Andrejs ^b   Jaunalksne, Inta ^a   Serova, Jelena ^a   Ievins, Talis ^a   Bjertnaes, Lars J ^c   Vanags, Indulis ^a,b  

^a PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Acute respiratory distress syndrome; Lung injury; Plasminogen activator inhibitor 1; Tissue factor; Tissue plasminogen activator; Ventilator associated lung injury

Indexed keywords

EID: 85029538900     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2016.00064     Document Type: Article

References (36)

1. Donahoe M. Acute respiratory distress syndrome: a clinical review. Pulm Circ (2011) 1(2):192-211. doi: 10.4103/2045-8932.83454
2. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med (2012) 38(10):1573-82. doi:10.1007/s00134-012-2682-1
3. Terpstra ML, Aman J, van Nieuw Amerongen GP, Groeneveld AB. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis*. Crit Care Med (2014) 42(3):691-700. doi:10.1097/01.ccm.0000435669.60811.24
4. Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H. Acute respiratory distress syndrome: new definition, current and future therapeutic options. J Thorac Dis (2013) 5(3):326-34. doi:10.3978/j.issn.2072-1439.2013.04.05
5. Xue M, Sun Z, Shao M, Yin J, Deng Z, Zhang J, et al. Diagnostic and prognostic utility of tissue factor for severe sepsis and sepsis-induced acute lung injury. J Transl Med (2015) 13:172. doi:10.1186/s12967-015-0518-9
6. Ferguson ND, Frutos-Vivar F, Esteban A, Gordo F, Honrubia T, Penuelas O, et al. Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study. Crit Care (2007) 11(5):R96. doi:10.1186/cc6113
7. Iscimen R, Cartin-Ceba R, Yilmaz M, Khan H, Hubmayr RD, Afessa B, et al. Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med (2008) 36(5):1518-22. doi:10.1097/CCM.0b013e31816fc2c0
8. Kuzkov VV, Kirov MY, Sovershaev MA, Kuklin VN, Suborov EV, Waerhaug K, et al. Extravascular lung water determined with single transpulmonary thermodilution correlates with the severity of sepsis-induced acute lung injury. Crit Care Med (2006) 34(6):1647-53. doi:10.1097/01.CCM.0000218817.24208.2E
9. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med (2005) 353(16):1685-93. doi:10.1056/NEJMoa050333
10. Linko R, Okkonen M, Pettila V, Perttila J, Parviainen I, Ruokonen E, et al. Acute respiratory failure in intensive care units. FINNALI: a prospective cohort study. Intensive Care Med (2009) 35(8):1352-61. doi:10.1007/s00134-009-1519-z
11. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA (2016) 315(8):788-800. doi:10.1001/jama.2016.0291
12. Irish Critical Care Trials Group. Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management. Crit Care (2008) 12(1):R30. doi:10.1186/cc6808
13. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med (1994) 149(3 Pt 1):818-24. doi:10.1164/ajrccm.149.3.7509706
14. Villar J, Blanco J, Kacmarek RM. Current incidence and outcome of the acute respiratory distress syndrome. Curr Opin Crit Care (2016) 22(1):1-6. doi:10.1097/MCC.0000000000000266
15. Gong MN, Thompson BT. Acute respiratory distress syndrome: shifting the emphasis from treatment to prevention. Curr Opin Crit Care (2016) 22(1):21-37. doi:10.1097/MCC.0000000000000275
16. Rodrigues CD, Oliveira RA, Soares SM, Figueiredo LC, Araujo S, Dragosavac D. Lung injury and mechanical ventilation in cardiac surgery: a review. Rev Bras Ter Intensiva (2010) 22(4):375-83. doi:10.1590/S0103-507X2010000400011
17. Jozwiak M, Teboul JL, Monnet X. Extravascular lung water in critical care: recent advances and clinical applications. Ann Intensive Care (2015) 5(1):38. doi:10.1186/s13613-015-0081-9
18. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network. N Engl J Med (2000) 342(18):1301-8. doi:10.1056/NEJM200005043421801
19. McClintock D, Zhuo H, Wickersham N, Matthay MA, Ware LB. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care (2008) 12(2):R41. doi:10.1186/cc6846
20. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD, et al. Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N: pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med (2007) 35(8):1821-8. doi:10.1097/01.CCM.0000221922.08878.49
21. Idell S, Koenig KB, Fair DS, Martin TR, McLarty J, Maunder RJ. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol (1991) 261(4 Pt 1):L240-8
22. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 285(1):L20-8. doi:10.1152/ajplung.00312.2002
23. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med (2004) 30(1):51-61. doi:10.1007/s00134-003-2136-x
24. Sapru A, Curley MA, Brady S, Matthay MA, Flori H. Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. Intensive Care Med (2010) 36(1):157-63. doi:10.1007/s00134-009-1690-2
25. Altman DG. Statistics in the medical literature: 3. Stat Med (1999) 18(4):487-90. doi:10.1002/(SICI)1097-258(19990228)18:4<487::AID-SIM106>3.3.CO;2-A
26. Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR. Low levels of protein C are associated with poor outcome in severe sepsis. Chest (2001) 120(3):915-22. doi:10.1378/chest.120.3.915
27. Liu KD, Looney MR, Matthay MA. Inhaled activated protein C: a novel therapy for acute lung injury? Crit Care (2009) 13(3):150. doi:10.1186/cc7869
28. Angus DC. Drotrecogin alfa (activated).a sad final fizzle to a roller-coaster party. Crit Care (2012) 16(1):107. doi:10.1186/cc11152
29. Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA (2012) 307(23):2526-33. doi:10.1001/jama.2012.5669
30. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J Trauma (1999) 47(4):719-23. doi:10.1097/00005373-199910000-00017
31. van der Poll T. Tissue factor as an initiator of coagulation and inflammation in the lung. Crit Care (2008) 12(Suppl 6):S3. doi:10.1186/cc7026
32. Determann RM, Millo JL, Garrard CS, Schultz MJ. Bronchoalveolar levels of plasminogen activator inhibitor-1 and soluble tissue factor are sensitive and specific markers of pulmonary inflammation. Intensive Care Med (2006) 32(6):946-7. doi:10.1007/s00134-006-0167-9
33. Idell S, Peters J, James KK, Fair DS, Coalson JJ. Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage. J Clin Invest (1989) 84(1):181-93. doi:10.1172/JCI114217
34. El Solh AA, Bhora M, Pineda L, Aquilina A, Abbetessa L, Berbary E. Alveolar plasminogen activator inhibitor-1 predicts ARDS in aspiration pneumonitis. Intensive Care Med (2006) 32(1):110-5. doi:10.1007/s00134-005-2847-2
35. Wang ZH, Ren WY, Zhu L, Hu LJ. Plasminogen activator inhibitor-1 regulates LPS induced inflammation in rat macrophages through autophagy activation. ScientificWorldJournal (2014) 2014:189168. doi:10.1155/2014/189168
36. Ma J, Sun Q, Mi R, Zhang H. Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling. J Genet Genomics (2011) 38(11):533-7. doi:10.1016/j.jgg.2011.10.002